1 / 13

Atrial Fibrillation Ablation Market Size 2022

Rise in prevalence rate of atrial fibrillation in geriatric population, technological advancements in devices, improvement of healthcare infrastructure in developing countries, development of minimally invasive procedures, and increase in patient awareness propel the market growth. However, dearth of skilled professionals and unfavorable preference to pharmaceutical drugs hamper the growth of the market.Catheter ablation is the highest revenue contributor and is expected to grow at the highest CAGR of 13.8% in the analysis period. This growth is owing to the technological advancements such as cryoFORM, which offers increased flexibility that allows easy manipulation and treatment during surgical process. <br><br>Read more details at: https://www.alliedmarketresearch.com/atrial-fibrillation-market<br>

alliedmarketresearch
Télécharger la présentation

Atrial Fibrillation Ablation Market Size 2022

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Atrial Fibrillation Market Opportunities and Forecasts, 2014 – 2021 Pages: 138 Published: 2016

  2. ATRIAL FIBRILLATION MARKET Catheter ablation would propel the market growth with a very high rate, as these devices are used for the treatment of atrial fibrillation when medications are not effective. Catheter ablation procedure is very low risk and minimally-invasive in nature than other surgery (such as MAZE surgery). HemaliNarkhede

  3. ATRIAL FIBRILLATION MARKET OVERVIEW • Atrial Fibrillation MarketReport, published by Allied Market Research, forecasts that the global market is expected to garner $8,319 million by 2022, registering a CAGR of 13.0% during the period 2014 - 2022. • Non-surgical devices segment dominated the overall market in 2015. North America was the leading geographic segment in global atrial fibrillation devices market in 2015, and is expected to maintain its leading position throughout forecast period. • Rise in prevalence rate of atrial fibrillation in geriatric population, technological advancements in devices, improvement of healthcare infrastructure in developing countries, development of minimally invasive procedures, and increase in patient awareness propel the market growth. • Read more at : https://www.alliedmarketresearch.com/atrial-fibrillation-market

  4. TOP FACTORS IMPACTING GLOBAL ATRIAL FIBRILLATION MARKET

  5. ATRIAL FIBRILLATION MARKET KEY BENEFITS • In-depth analysis of the market is conducted based on market estimations of the key segments for the period of 2014‐2022. • Comprehensive analysis of factors that drive and restrict the growth of the global atrial fibrillation market is provided in the report. • Exhaustive analysis by different segments aids tounderstand the different aspects of atrial fibrillation that are currently used along with the variants that would gain prominence in the future. • Competitive intelligence of leading manufacturers and distributors interprets the competitive scenario across various geographies. • Key market players and their strategies are analyzed thoroughly, to predict the competitive outlook of the global atrial fibrillation market share.

  6. MEXICO: ATRIAL FIBRILLATION MARKET ($MILLION)

  7. ATRIAL FIBRILLATION MARKET KEY FINDINGS • North America dominated the market of atrial fibrillation and is expected to maintain its lead throughout the forecast period, with a CAGR of 12.1% • Asia-Pacific is the fastest growing market and is estimated to grow at a CAGR of 14.7% • Japan accounted for more than one-third share of the Asia-Pacific atrial fibrillation devices market in 2015 • The non-surgical equipment segment dominated in 2015, occupying largest revenue share and is anticipated to grow at a CAGR of 12.5% • Catheter ablation (sub segment for surgical equipment) accounted for largest market share in 2015 and is anticipated to grow at a CAGR of 13.8%

  8. TOP INVESTMENT POCKETS IN GLOBAL ATRIAL FIBRILLATION MARKET

  9. KEY PLAYERS IN INDUSTRY • Abbott Laboratories, • Johnson & Johnson, • MicroPortScientific Corporation, • Boston Scientific Corporation, • St. Jude Medical, Inc., • Medtronic plc, • BiotronikSE & Co. KG, • KoninklijkePhilips N.V., • Siemens AG, • AtriCureInc. • Download free Sample Report : • https://www.alliedmarketresearch.com/request-toc/479

  10. ATRIAL FIBRILLATION MARKET SEGMENTATION

  11. CATHETER ABLATION MARKET, BY TYPE, 2015 Catheter ablation is the most commonly used surgical devices for the treatment of cardiac arrhythmias. It is recommended for the treatment of AF when anticoagulant drugs and other medications cannot be administered or tolerated by the patient. Therefore, this segment accounted for the major chunk of the overall market in 2015 and is expected to be the fastest-growing market during the forecast period.

  12. ATRIAL FIBRILLATION MARKET BY GEOGRAPHY • North America, Europe, Asia-Pacific, LAMEA

  13. Thank You! For More Details Visit us at https://www.alliedmarketresearch.com/atrial-fibrillation-market Follow Us On

More Related